BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692927)

  • 1. Expression of GPIV and N(aka) antigen on monocytes in N(aka)-negative subjects whose platelets lack GPIV.
    Take H; Kashiwagi H; Tomiyama Y; Honda S; Honda Y; Mizutani H; Furubayashi T; Karasuno T; Nishiura T; Kanayama Y
    Br J Haematol; 1993 Jul; 84(3):387-91. PubMed ID: 7692927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes.
    Yamamoto N; Akamatsu N; Sakuraba H; Yamazaki H; Tanoue K
    Blood; 1994 Jan; 83(2):392-7. PubMed ID: 7506948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36).
    Yamamoto N; Ikeda H; Tandon NN; Herman J; Tomiyama Y; Mitani T; Sekiguchi S; Lipsky R; Kralisz U; Jamieson GA
    Blood; 1990 Nov; 76(9):1698-703. PubMed ID: 1699620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
    Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
    Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay.
    Thibert V; Bellucci S; Edelman L; Tandon NN; Legrand C
    Thromb Haemost; 1992 Nov; 68(5):600-5. PubMed ID: 1280864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation results in a redistribution of glycoprotein IV (CD36).
    Michelson AD; Wencel-Drake JD; Kestin AS; Barnard MR
    Arterioscler Thromb; 1994 Jul; 14(7):1193-201. PubMed ID: 7517184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians.
    Curtis BR; Aster RH
    Transfusion; 1996 Apr; 36(4):331-4. PubMed ID: 8623134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the human CD36 leucocyte differentiation antigen by means of the monoclonal antibody NL07.
    Alessio M; Ghigo D; Garbarino G; Geuna M; Malavasi F
    Cell Immunol; 1991 Oct; 137(2):487-500. PubMed ID: 1716523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.
    Tandon NN; Kralisz U; Jamieson GA
    J Biol Chem; 1989 May; 264(13):7576-83. PubMed ID: 2468670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesive functions of platelets lacking glycoprotein IV (CD36).
    Tandon NN; Ockenhouse CF; Greco NJ; Jamieson GA
    Blood; 1991 Dec; 78(11):2809-13. PubMed ID: 1720035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V.
    Stockelberg D; Hou M; Rydberg L; Kutti J; Wadenvik H
    Transfus Med; 1996 Sep; 6(3):243-8. PubMed ID: 8885154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet adhesion to collagen in individuals lacking glycoprotein IV.
    McKeown L; Vail M; Williams S; Kramer W; Hansmann K; Gralnick H
    Blood; 1994 May; 83(10):2866-71. PubMed ID: 7514049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV.
    Tomiyama Y; Take H; Ikeda H; Mitani T; Furubayashi T; Mizutani H; Yamamoto N; Tandon NN; Sekiguchi S; Jamieson GA
    Blood; 1990 Feb; 75(3):684-7. PubMed ID: 2297570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction.
    Beer JH; Rabaglio M; Berchtold P; von Felten A; Clemetson KJ; Tsakiris DA; Kehrel B; Brandenberger S
    Blood; 1993 Aug; 82(3):820-9. PubMed ID: 7687896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
    Kieffer N; Guichard J; Breton-Gorius J
    Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin binds normally to glycoprotein IIIb deficient platelets.
    Kehrel B; Kronenberg A; Schwippert B; Niesing-Bresch D; Niehues U; Tschöpe D; van de Loo J; Clemetson KJ
    Biochem Biophys Res Commun; 1991 Sep; 179(2):985-91. PubMed ID: 1716890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A resolution of reported discrepancies in the characteristics of platelet glycoproteins IV (GPIV) and IIIb (GPIIIb).
    Yamamoto N; de Romeuf C; Tandon NN; Jamieson GA
    Thromb Haemost; 1990 Feb; 63(1):97-102. PubMed ID: 1692640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.
    Silverstein RL; Asch AS; Nachman RL
    J Clin Invest; 1989 Aug; 84(2):546-52. PubMed ID: 2474571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
    Lin M; Xu X; Lee HL; Liang DC; Santoso S
    Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
    Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J
    Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.